Schedule 13G ownership disclosure
MILESTONE PHARMACEUTICALS IN
Security class unavailable · CUSIP: 59935V107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-043131
- Form type
- SC 13G
- Filer
- Forbion Capital Fund III Cooperatief U.A.
- CIK
- CIK 1747586
- Filed
- Feb 16, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership